Note 13 - Subsequent Events
|12 Months Ended|
Jun. 30, 2017
|Notes to Financial Statements|
|Subsequent Events [Text Block]||
July 2017,management determined that CyVek achieved the required revenue threshold for the additional consideration payment discussed in Note
4resulting in a payment of
$34.0million to the former owners.
September 5, 2017,Bio-Techne acquired Trevigen Inc for approximately
$11.0million. The purchase accounting for this acquisition is in progress.
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
Reference 1: http://www.xbrl.org/2003/role/presentationRef